Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

458
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
458
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

988
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
988
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

258
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
258
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

535
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
535
Factors Influencing Drug Absorption: Physicochemical Parameters01:22

Factors Influencing Drug Absorption: Physicochemical Parameters

412
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
412

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Terson's Syndrome with Roth Spot-Resembling Features and Third Nerve Palsy without Radiologically Diagnosed Subarachnoid Haemorrhage.

Vision (Basel, Switzerland)·2024
Same author

Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study.

Current HIV research·2024
Same author

Instances of Biowarfare in World War I (1914-1918).

Cureus·2024
Same author

Development of Analytical Method for the Quantitation of Monoclonal Antibodies Solutions via Raman Spectroscopy: The Case of Bevacizumab.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

The History of Anthrax Weaponization in the Soviet Union.

Cureus·2023
Same author

Impact of Cataract Surgery on IOP and Ocular Structures in Normotensive Patients and Primary and Exfoliation Open-Angle Glaucoma Patients.

Clinical ophthalmology (Auckland, N.Z.)·2023

Related Experiment Video

Updated: Sep 3, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

326

Nanotechnology-based formulations to amplify intraocular bioavailability.

Konstantinos Kagkelaris1, George Panayiotakopoulos2, Constantinos D Georgakopoulos3

  • 1Department of Ophthalmology, School of Medicine, University of Patras, 26500 Patras, Greece.

Therapeutic Advances in Ophthalmology
|July 25, 2022
PubMed
Summary
This summary is machine-generated.

Ophthalmic drug delivery faces challenges with low bioavailability in the anterior eye segment. Innovative nanotechnology formulations, including nanoparticles and inserts, aim to improve drug delivery and patient compliance for anterior eye diseases.

Keywords:
bioavailabilitynanotechnologyophthalmologytopical formulations

More Related Videos

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
07:12

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

2.5K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

976

Related Experiment Videos

Last Updated: Sep 3, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

326
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
07:12

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

2.5K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

976

Area of Science:

  • Ophthalmology
  • Pharmaceutics
  • Nanotechnology

Background:

  • Topical ophthalmic drug delivery via eye drops and ointments faces significant challenges due to ocular barriers, resulting in low bioavailability.
  • Low bioavailability necessitates increased dosing, leading to amplified side effects and poor patient compliance, especially in chronic treatments for anterior segment eye diseases.
  • Current research prioritizes novel drug delivery strategies to enhance ocular bioavailability and establish safer, more convenient dosing regimens.

Purpose of the Study:

  • To review and present the latest advancements in ocular drug delivery formulations.
  • Focus on strategies targeting the anterior segment of the eye.
  • Highlight innovative approaches to overcome bioavailability limitations.

Main Methods:

  • Review of current literature on ocular drug delivery systems.
  • Summarization of nanotechnology-based formulations (organic and inorganic nanoparticles).
  • Inclusion of nanoparticle-laden therapeutic contact lenses, in situ gelling systems, and ocular inserts.

Main Results:

  • Nanotechnology offers diverse formulations like liposomes, niosomes, dendrimers, nanoemulsions, nanosuspensions, and nanoparticles.
  • Therapeutic contact lenses, in situ gelling systems, and ocular inserts represent advanced delivery platforms.
  • These innovative systems show potential for improved drug penetration and sustained release in the anterior eye segment.

Conclusions:

  • Innovative ocular drug delivery systems, particularly nanotechnology-based ones, are crucial for improving therapeutic outcomes in anterior segment eye diseases.
  • Advanced formulations like nanoparticle-laden contact lenses and in situ gelling systems offer promising alternatives to conventional methods.
  • Further research into these novel delivery strategies can lead to enhanced drug efficacy, reduced side effects, and better patient compliance.